Patient # |
Hematological disease |
1 |
ALL |
2 |
AML |
3 |
AML |
4 |
AML |
5 |
AML |
6 |
AML |
7 |
AML |
8 |
AML |
9 |
AML |
10 |
AML |
11 |
AML |
12 |
BAL |
13 |
CML |
14 |
Hodgkin lymphoma |
15 |
Hodgkin lymphoma |
16 |
Hodgkin lymphoma |
17 |
MDS & MPS |
18 |
Multiple myeloma |
19 |
Multiple myeloma |
20 |
Multiple myeloma |
21 |
MDS |
22 |
MDS |
23 |
MDS |
24 |
MDS |
25 |
MDS |
26 |
MDS |
27 |
MDS |
28 |
NHL |
29 |
NHL |
30 |
NHL |
31 |
NHL |
32 |
Secondary acute leukemia |
|
Abbreviations: ALL:Acute Lymphoid Leukemia; AML:Acute Myeloid Leukemia;BAL:Biphenotypic Acute Leukemia; CML:Chronic Myeloid Leukemia;
MDS:Myelo-dysplastic Syndrome; MPS:MyeloproliferativeSyndrome; NHL: Non-Hodgkin Lymphoma |
Table 3f: Clinico-pathological characteristics of patients with hematological
malignancies. |